Womens Health Focus DCL positions itself as a preferred partner for women's health diagnostics and offers molecular testing capabilities. Target OB/GYN practices, fertility clinics, and women's health networks by highlighting its consultative pathology approach and access to specialized panels.

Clinical Trials Outsourcing DCL provides anatomic pathology services in global clinical trials in collaboration with large central laboratories and CROs. This creates a compelling value proposition for pharma and medical device sponsors seeking scalable, regionally accessible pathology partners in the Midwest.

Midwest Expansion As a regional lab with Midwest coverage, DCL can offer faster logistics, localized specimen handling, and scalable pathology and molecular testing for hospitals, clinics, and trial sites seeking reliable regional capacity.

Outsourcing Advantage DCL's mid-sized, private profile and personalized service can be marketed as a cost-efficient outsourcing option for mid-market hospitals and specialty clinics that require high-touch pathology services and faster turnarounds compared to large labs.

Strategic Partnership Equity backing from Thompson Street Capital Partners signals growth potential and financing flexibility to scale sales, marketing, and lab capacity. Focus outreach on partnerships to accelerate expansion in molecular diagnostics, trial services, and women's health offerings.